Preparation method and application of L-5-methyltetrahydrofolate calcium

By using non-precious metal catalysts and chiral separation of toluenesulfonic acid, the problems of purity and cost in the preparation of L-5-methyltetrahydrofolate in the prior art were solved, and the preparation effect of high purity and low cost was achieved .

CN116514815BActive Publication Date: 2024-11-26北京斯利安药业有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310318662.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-03-28
Publication Date
2024-11-26
Estimated Expiration
2043-03-28

AI Technical Summary

Technical Problem

It is difficult to effectively prepare high-purity calcium L-5-methyltetrahydrofolate in the prior art, and the traditional method uses precious metal catalysts with high risks and high costs, and the risk of benzene residue during chiral separation is high.

Method used

Non-precious metal catalysts such as lithium chloride and lithium hydroxide are used to combine with p-toluenesulfonic acid for chiral separation, reducing costs and risks, and improving product purity and yield by optimizing process conditions.

Benefits of technology

The high purity preparation of L-5-methyltetrahydrofolate calcium is achieved, reducing the risk of impurity degradation and benzene residue, simplifying the process, reducing costs, and suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004153810610000111
    Figure BDA0004153810610000111
  • Figure BDA0004153810610000132
    Figure BDA0004153810610000132
Patent Text Reader

Abstract

The invention provides a method for preparing L-5-methyltetrahydrofolate calcium, comprising the steps of: mixing folic acid, a first reductant, a first catalyst with a first alkaline solvent, performing a reduction reaction, and preparing (R, S)-6-tetrahydrofolate; mixing (R, S)-6-tetrahydrofolate, p-toluenesulfonic acid with a first antioxidant, performing chiral separation, and preparing 6(S)-tetrahydrofolate p-toluenesulfonate; mixing 6(S)-tetrahydrofolate p-toluenesulfonate, a methylating agent with a second alkaline solvent, performing a methylation reaction, mixing the product of the methylation reaction, a second reductant with a second catalyst, performing a ring-opening reaction, and preparing L-5-methyltetrahydrofolate; mixing L-5-methyltetrahydrofolate, a second antioxidant with a third alkaline solvent, decolorizing, filtering, taking the filtrate and calcium salt for salt-forming reaction, and preparing L-5-methyltetrahydrofolate calcium. The product yield and purity obtained by the preparation method are both high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical technology, and in particular to a preparation method of L-5-methyltetrahydrofolate calcium and application thereof. Background Art

[0002] L-5-Methyltetrahydrofolate (L-5-MTHF) is a new type of folic acid drug. It is often known as the main ingredient of food additives and nutritional supplements. L-5-MTHF participates in many important biochemical reactions in the body and has important pharmacological effects. This type of drug can pass through the blood-brain barrier and can prevent symptoms such as Alzheimer's disease and cellular anemia. Compared with other drugs, L-5-MTHF has the characteristics of significant efficacy, complete functions and few side effects, and has gradually become a focus of common concern in the fields of medicine and pharmaceutical research. As people conduct more in-depth research on it, L-5-MTHF has gradually been applied to drugs and foods.

[0003] There are many reports about L-5-MTHF, but due to its own defects such as poor stability and sensitivity to oxygen, it has not been widely industrialized in production. At present, there is no manufacturer in my country that produces L-5-MTHF. However, there are many manufacturers in my country that produce folic acid, and the price of folic acid is relatively low, so using folic acid as a raw material to produce L-5-MTHF will have broad prospects.

[0004] The National Health and Family Planning Commission issued the Announcement No. 13 of 2017 on the New Variety of Food Nutrition Fortifiers 6S-5-Methyltetrahydrofolate Calcium and Nitrogen and the Expanded Use of 8 Food Additives. According to the provisions of the Food Safety Law of the People's Republic of China, the review agency organized experts to review and approve the safety assessment materials of the new variety of food nutrition additives 6S-5-Methyltetrahydrofolate Calcium and nitrogen and other 8 food additives with expanded use scope. 6S-5-Methyltetrahydrofolate calcium can be used to prepare milk powder (except children's milk powder and milk powder for pregnant women) and solid beverages, and the amount used is consistent with the amount of folic acid specified in GB14880.

[0005] The traditional method for preparing 6S-5-methyltetrahydrofolate calcium usually cannot obtain a high product purity, generally only about 90% purity, and most of them use heavy metals such as platinum oxide, lead nitrate or other harmful metals as catalysts, which are high in risk and cost. In addition, the traditional method for preparing 6S-5-methyltetrahydrofolate calcium uses benzenesulfonic acid for chiral separation, resulting in a high risk of benzene residue. Summary of the invention

[0006] Based on this, the present invention provides a method for preparing L-5-methyltetrahydrofolate calcium, which has high product yield, high purity, simple process, safety, environmental protection and low cost.

[0007] The present invention is achieved through the following technical solutions.

[0008] A method for preparing L-5-methyltetrahydrofolate calcium comprises the following steps:

[0009] Mixing folic acid, a first reducing agent, a first catalyst and a first alkaline solvent to perform a reduction reaction to prepare (R,S)-6-tetrahydrofolic acid;

[0010] The (R,S)-6-tetrahydrofolate, p-toluenesulfonic acid and the first antioxidant are mixed and chiral separation is performed to prepare 6(S)-tetrahydrofolate p-toluenesulfonate;

[0011] The 6(S)-tetrahydrofolate p-toluenesulfonate, the methylating agent and the second alkaline solvent are mixed to perform a methylation reaction, and the product of the methylation reaction, the second reducing agent and the second catalyst are mixed to perform a ring-opening reaction to prepare L-5-methyltetrahydrofolate;

[0012] The L-5-methyltetrahydrofolate, the second antioxidant and the third alkaline solvent are mixed, decolorized, filtered, and the filtrate is reacted with calcium salt to form a salt to prepare L-5-methyltetrahydrofolate calcium;

[0013] Wherein, the first catalyst and the second catalyst are independently selected from one or more of lithium chloride, lithium hydroxide, lithium carbonate and lithium sulfate;

[0014] The first alkaline solvent, the second alkaline solvent and the third alkaline solvent are independently selected from a 3% to 5% sodium hydroxide aqueous solution, a 4% to 6% potassium hydroxide aqueous solution or a 5% to 7% sodium carbonate aqueous solution.

[0015] In one embodiment, the first antioxidant is selected from one or more of thiourea dioxide and L-cysteine ​​hydrochloride; and / or

[0016] The second antioxidant is selected from one or more of tea polyphenols, antioxidant 168, antioxidant 1010, antioxidant B215, antioxidant B225, L-cysteine, sodium pyrosulfite and calcium ascorbate.

[0017] In one embodiment, the first reducing agent and the second reducing agent are independently selected from one or more of sodium borohydride, sodium cyanoborohydride and sodium triacetoxyborohydride.

[0018] In one embodiment, the calcium salt is selected from one or more of calcium chloride, calcium chloride dihydrate, calcium lactate, calcium acetate and calcium aspartate.

[0019] In one embodiment, the mass ratio of the folic acid, the first reducing agent and the first catalyst is 1:(0.6-1.2):(0.02-0.05); and / or

[0020] The mass ratio of the (R, S)-6-tetrahydrofolate, the p-toluenesulfonic acid and the first antioxidant is 1:(0.48-0.55):(0.01-0.1); and / or

[0021] The mass ratio of the 6(S)-tetrahydrofolate toluenesulfonate, the methylating agent, the second reducing agent and the second catalyst is 1:(0.12-0.16):(0.03-0.07):(0.02-0.05); and / or

[0022] The mass ratio of the L-5-methyltetrahydrofolate, the second antioxidant and the calcium salt is 1:(0.02-0.1):(0.5-1.2).

[0023] In one embodiment, the reaction temperature of the reduction reaction is 0°C to 30°C.

[0024] In one embodiment, the methylation reaction satisfies one or more of the following conditions:

[0025] (1) The reaction temperature is 15°C to 30°C;

[0026] (2) The reaction time is 20 min to 60 min.

[0027] In one embodiment, the ring-opening reaction satisfies one or more of the following conditions:

[0028] (1) The reaction temperature is 65°C to 75°C;

[0029] (2) The reaction time is 2h to 5h.

[0030] In one embodiment, the salt-forming reaction satisfies one or more of the following conditions:

[0031] (1) The reaction temperature is 90°C to 95°C;

[0032] (2) pH is 7.5-7.8.

[0033] The present invention also provides an application of the preparation method of the L-5-methyltetrahydrofolate calcium in medicines, foods or health products.

[0034] Compared with the prior art, the preparation method of L-5-methyltetrahydrofolate calcium of the present invention has the following beneficial effects:

[0035] The present invention selects one or more of lithium chloride, lithium hydroxide, lithium carbonate and lithium sulfate as catalysts, which not only reduces the risk but also reduces the cost compared with traditional precious metal catalysts. At the same time, the inventors found that the use of an alkaline solvent with a mass fraction of 3% to 5% can effectively reduce the degradation of impurities caused by excessive local alkalinity, thereby significantly improving the purity of the product. In addition, the present invention selects p-toluenesulfonic acid to replace traditional benzenesulfonic acid in the chiral separation process, which can not only reduce the risk of benzene residues, but also save materials and time, and reduce the amount of three wastes.

[0036] Furthermore, the preparation method of L-5-methyltetrahydrofolate calcium of the present invention has simple process, is safe and environmentally friendly, requires cheap and readily available raw materials, has low cost, and can realize industrial production. DETAILED DESCRIPTION

[0037] For ease of understanding of the present invention, the present invention will be described more fully below with reference to relevant embodiments. Preferred embodiments of the present invention are provided in the embodiments. However, the present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.

[0038] In addition, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Therefore, the features defined as "first" and "second" may explicitly or implicitly include at least one of the features. In the description of the invention, the meaning of "multiple" is at least two, such as two, three, etc., unless otherwise clearly and specifically defined. In the description of the present invention, the meaning of "several" is at least one, such as one, two, etc., unless otherwise clearly and specifically defined.

[0039] The words "preferably", "more preferably", etc. in the present invention refer to embodiments of the present invention that may provide certain beneficial effects in certain circumstances. However, other embodiments may also be preferred under the same circumstances or other circumstances. In addition, the description of one or more preferred embodiments does not imply that other embodiments are not applicable, nor is it intended to exclude other embodiments from the scope of the present invention.

[0040] When a numerical range is disclosed herein, the above range is considered to be continuous and includes the minimum and maximum values ​​of the range, as well as every value between such minimum and maximum values. Further, when a range refers to an integer, every integer between the minimum and maximum values ​​of the range is included. In addition, when multiple ranges are provided to describe features or characteristics, the ranges can be combined. In other words, unless otherwise indicated, all ranges disclosed herein should be understood to include any and all subranges included therein.

[0041] Unless otherwise specified, all percentages, fractions and ratios are calculated by the total mass of the composition of the present invention. Unless otherwise specified, all masses of the listed ingredients are given as active substances, so they do not include solvents or by-products that may be contained in commercially available materials. The term "mass percentage content" herein can be represented by the symbol "%". Unless otherwise specified, all molecular weights herein are weight average molecular weights expressed in Daltons. Unless otherwise specified, all formulations and tests herein occur in an environment of 25°C. "Including", "including", "containing", "containing", "having" or other variants herein are intended to cover non-closed inclusions, and no distinction is made between these terms. The term "comprising" means that other steps and ingredients that do not affect the final result can be added. The composition and method / process of the present invention include, consist of and are substantially composed of the necessary elements and restrictions described herein and any additional or optional ingredients, components, steps or restrictions described herein. No distinction is made between the terms "efficacy", "performance", "effect" and "efficacy" herein.

[0042] The weight of the relevant components mentioned in the description of the embodiments of the present invention can not only refer to the specific content of each component, but also represent the proportional relationship between the weights of the components. Therefore, as long as the content of the relevant components is proportionally enlarged or reduced according to the description of the embodiments of the present invention, it is within the scope disclosed in the description of the embodiments of the present invention. Specifically, the weight described in the description of the embodiments of the present invention can be a mass unit known in the chemical industry such as ug, mg, g, kg, etc.

[0043] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.

[0044] The present invention provides a method for preparing L-5-methyltetrahydrofolate calcium, comprising the following steps:

[0045] Mixing folic acid, a first reducing agent, a first catalyst and a first alkaline solvent to perform a reduction reaction to prepare (R,S)-6-tetrahydrofolic acid;

[0046] (R,S)-6-tetrahydrofolic acid, p-toluenesulfonic acid and a first antioxidant are mixed and chiral separation is performed to prepare 6(S)-tetrahydrofolic acid p-toluenesulfonate;

[0047] Mixing 6(S)-tetrahydrofolate p-toluenesulfonate, a methylating agent and a second alkaline solvent to perform a methylation reaction, and mixing a product of the methylation reaction, a second reducing agent and a second catalyst to perform a ring-opening reaction to prepare L-5-methyltetrahydrofolate;

[0048] The L-5-methyltetrahydrofolate, the second antioxidant and the third alkaline solvent are mixed, decolorized, filtered, and the filtrate is reacted with calcium salt to form a salt to prepare L-5-methyltetrahydrofolate calcium;

[0049] Wherein, the first catalyst and the second catalyst are independently selected from one or more of lithium chloride, lithium hydroxide, lithium carbonate and lithium sulfate;

[0050] The first alkaline solvent, the second alkaline solvent and the third alkaline solvent are independently selected from a 3% to 5% sodium hydroxide aqueous solution, a 4% to 6% potassium hydroxide aqueous solution or a 5% to 7% sodium carbonate aqueous solution.

[0051] The present invention uses one or more of lithium chloride, lithium hydroxide, lithium carbonate and lithium sulfate to replace traditional metal lead or platinum as a catalyst, which can reduce risks and costs. At the same time, the present invention uses p-toluenesulfonic acid to replace traditional benzenesulfonic acid in the chiral separation process, which can not only reduce the risk of benzene residue, but also directly perform product chiral separation, combining two steps into one step to save materials and time, and reduce the amount of three wastes.

[0052] It can be understood that in the present invention, the mass fraction of sodium hydroxide in the sodium hydroxide aqueous solution includes but is not limited to 3%, 3.2%, 3.4%, 3.6%, 3.7%, 3.8%, 3.9%, 4%, 4.1%, 4.2%, 4.3%, 4.4%, 4.6%, 4.8%, and 5%; more specifically, the first alkaline solvent, the second alkaline solvent, and the third alkaline solvent are sodium hydroxide aqueous solutions with a mass fraction of 4%.

[0053] It can be understood that in the present invention, the mass fraction of potassium hydroxide in the potassium hydroxide aqueous solution includes but is not limited to 4%, 4.2%, 4.4%, 4.6%, 4.8%, 5%, 5.2%, 5.4%, 5.6%, 5.8%, 6%;

[0054] It can be understood that in the present invention, the mass fraction of sodium carbonate in the sodium carbonate aqueous solution includes but is not limited to 5%, 5.2%, 5.4%, 5.6%, 5.8%, 6%, 6.2%, 6.4%, 6.6%, 6.8%, and 7%.

[0055] The inventors unexpectedly discovered that replacing the method of adjusting the alkali with high-concentration sodium hydroxide after adding water in the traditional preparation method with 3% to 5% sodium hydroxide, 4% to 6% potassium hydroxide or 5% to 7% sodium carbonate by mass can effectively reduce the degradation of impurities caused by excessive local alkalinity, thereby significantly improving the purity of the product.

[0056] More specifically, the preparation of (R,S)-6-tetrahydrofolate comprises the following steps:

[0057] Folic acid and a first alkaline solvent are added to a reaction kettle, and a first catalyst and a first reducing agent are added in sequence under stirring to carry out a reduction reaction.

[0058] More specifically, the preparation of 6(S)-tetrahydrofolate toluenesulfonate comprises the following steps:

[0059] (R, S)-6-tetrahydrofolic acid, p-toluenesulfonic acid and the first antioxidant are mixed, and then the first acid is added, the pH of the feed solution is adjusted to 0.5-1.2, and the solution is centrifuged to perform chiral separation.

[0060] In a specific example, the first acid is selected from one or more of hydrochloric acid, sulfuric acid, benzenesulfonic acid, p-toluenesulfonic acid and citric acid. More specifically, the first acid is 10% to 40% sulfuric acid.

[0061] More specifically, the preparation of L-5-methyltetrahydrofolate comprises the following steps:

[0062] 6(S)-tetrahydrofolate toluenesulfonate is mixed with a second alkaline solvent, the pH is adjusted to 7.5-8.0, and a methylating agent is added to carry out a methylation reaction. After the methylation reaction is completed, a second catalyst and a second reducing agent are added in sequence with stirring to carry out a ring-opening reaction. After the ring-opening reaction is completed, the pH is adjusted to 2.8-4.6 with a second acid, and then filtered, and the filter cake is dried.

[0063] In a specific example, the second acid is selected from one or more of hydrochloric acid, sulfuric acid, benzenesulfonic acid, p-toluenesulfonic acid and citric acid. More specifically, the acid is 10% to 40% sulfuric acid. More specifically, the second acid is hydrochloric acid.

[0064] More specifically, the preparation of L-5-methyltetrahydrofolate calcium comprises the following steps:

[0065] The pH of the L-5-methyltetrahydrofolate system is adjusted to 7.0±0.2 with a third alkaline solvent, a second antioxidant is added, and activated carbon is added for decolorization, and then filtered, and the filtrate is dripped into a calcium salt heated to above 90° C., and the pH of the system is adjusted to 7.5-7.8 with a third alkaline solvent, filtered, slurried with water, filtered, the filter cake is slurried with water, filtered, washed, and dried.

[0066] The inventors have found that the reverse high-temperature dropwise addition in the process of preparing L-5-methyltetrahydrofolate calcium can significantly improve the product quality.

[0067] In a specific example, the first antioxidant is selected from one or more of thiourea dioxide and L-cysteine ​​hydrochloride.

[0068] In a specific example, the second antioxidant is selected from one or more of tea polyphenols, antioxidant 168, antioxidant 1010, antioxidant B215, antioxidant B225, L-cysteine, sodium pyrosulfite and calcium ascorbate.

[0069] Preferably, the second antioxidant is selected from tea polyphenols, a mixture of antioxidant 1010 and L-cysteine, or a mixture of calcium ascorbate and antioxidant 168.

[0070] In the present invention, the use of antioxidant 168 and calcium ascorbate can greatly improve the stability of the product salt-forming process.

[0071] In a specific example, the first reducing agent and the second reducing agent are independently selected from one or more of sodium borohydride, sodium cyanoborohydride and sodium triacetoxyborohydride.

[0072] In a specific example, the calcium salt is selected from one or more of calcium chloride, calcium chloride dihydrate, calcium lactate, calcium acetate and calcium aspartate.

[0073] In a specific example, the methylating agent is an aqueous formaldehyde solution.

[0074] In a specific example, the agent used for decolorization is activated carbon.

[0075] More specifically, the activated carbon is selected from one or more of medicinal 767 activated carbon, Egret A activated carbon and Egret P activated carbon.

[0076] In a specific example, the bleaching temperature is 20° C. to 40° C., and the bleaching time is 1 h to 4 h.

[0077] In a specific example, the mass ratio of folic acid, the first reducing agent and the first catalyst is 1:(0.6-1.2):(0.02-0.05).

[0078] In a specific example, the mass ratio of (R,S)-6-tetrahydrofolate, p-toluenesulfonic acid and the first antioxidant is 1:(0.48-0.55):(0.01-0.1).

[0079] In a specific example, the mass ratio of 6(S)-tetrahydrofolate toluenesulfonate, the methylating agent, the second reducing agent and the second catalyst is 1:(0.12-0.16):(0.03-0.07):(0.02-0.05).

[0080] In a specific example, the mass ratio of L-5-methyltetrahydrofolate, the second antioxidant and the calcium salt is 1:(0.02-0.1):(0.5-1.2).

[0081] In a specific example, the reaction temperature of the reduction reaction is 0°C to 30°C.

[0082] In a specific example, the methylation reaction satisfies one or more of the following conditions:

[0083] (1) The reaction temperature is 15°C to 30°C;

[0084] (2) The reaction time is 20 min to 60 min.

[0085] In a specific example, the ring-opening reaction satisfies one or more of the following conditions:

[0086] (1) The reaction temperature is 65°C to 75°C;

[0087] (2) The reaction time is 2h to 5h.

[0088] In a specific example, the salt-forming reaction satisfies one or more of the following conditions:

[0089] (1) The reaction temperature is 90°C to 95°C;

[0090] (2) pH is 7.5-7.8.

[0091] In a specific example, the chiral separation further includes a purification step.

[0092] More specifically, the chiral separation further includes the following steps:

[0093] The chiral separation product is dissolved in a first alkaline solvent, the pH of the feed solution is adjusted to 5-8, p-toluenesulfonic acid and the first acid are added, the pH of the feed solution is adjusted to 0.5-1.2, and then centrifuged and dried.

[0094] In a specific example, the ring-opening reaction further includes a purification step.

[0095] More specifically, after the ring-opening reaction, the following steps are also included: adjusting the pH of the product of the ring-opening reaction to 7.0±0.1 with a second alkaline solvent, then dripping in a calcium salt preheated to above 90°C, and at the same time adjusting the system to 7.5±0.2 with a second alkaline solvent to ensure that the system temperature is ≥80°C, heating to 92°C to 96°C after the dropwise addition is completed, controlling the pH to 7.5±0.1, reacting for 1 to 3 hours, filtering, taking the filter cake, adding water and L-cysteine, heating to 60°C±5°C, adjusting the pH to 2.8 to 4.6 with hydrochloric acid, filtering, washing, and drying.

[0096] The present invention also provides an application of the preparation method of the L-5-methyltetrahydrofolate calcium in medicines, foods or health products.

[0097] The preparation method of L-5-methyltetrahydrofolate calcium of the present invention is further described in detail below in conjunction with specific examples. The raw materials used in the following examples, unless otherwise specified, are all commercially available products.

[0098] Example 1

[0099] This embodiment provides a method for preparing L-5-methyltetrahydrofolate calcium, and the synthesis route is as follows:

[0100]

[0101] 500.0g of folic acid was added with 2.5kg of 4% sodium hydroxide and 20.0g of anhydrous lithium chloride, stirred at room temperature for 1 hour, and 300.0g of sodium borohydride was added in batches after about 2 hours, and the temperature was controlled at 0-30°C, and the reaction was allowed to proceed overnight. 30% sulfuric acid was added dropwise, and 500.0g of 50% p-toluenesulfonic acid was added dropwise after no more gas was generated in large quantities. When about half of the addition was completed, 20.0g of thiourea dioxide was added, the temperature was raised to 55-65°C, and 30% sulfuric acid was continued to be added dropwise to adjust the system pH to 0.6-1.2, and the crude product A was obtained by filtering and washing with water.

[0102] The crude product A was stirred with about 2.5 kg of 4% sodium hydroxide to dissolve, and the temperature was raised to 55-65° C. to adjust the system pH to 5.5-7.5, 30% sulfuric acid was added dropwise to adjust the system pH to 0.5-1.2, and 15.0 g of p-toluenesulfonic acid was added, stirred for 1.5 hours, filtered, rinsed with water and methanol in turn, and dried at 50-70° C. to obtain a refined product A: p-toluenesulfonate of 6(s)-tetrahydrofolate, about 275.0 g, with a yield of 39% and a purity of 98%.

[0103] Take 275.0g of refined product A, add about 1.3kg of 4% sodium hydroxide, adjust the pH of the system to 7.5-8.0, add 11.0g of L-cysteine ​​and 38.5g of formaldehyde (36%-38% aqueous solution), react at room temperature for 30min, add 11.0g of lithium chloride, slowly add 13.8g of sodium borohydride, raise the temperature to 60-70°C and react for 3.5h, add hydrochloric acid dropwise to adjust the pH of the system to 2.8-4.6, stir for 0.5-2.0 hours until it is evenly dispersed, filter, rinse with water and methanol in turn, and vacuum dry to obtain crude product B: crude L-5-methyltetrahydrofolate, 190.0g, yield 93%, purity 98%.

[0104] The crude product B was added with 4% sodium hydroxide to adjust the system pH to 7.0±0.1, 7.6 g of L-cysteine ​​was added, and the mixture was dripped into 15 parts of an aqueous solution (containing 133.0 g of calcium chloride dihydrate and heated to above 90°C), and 4% sodium hydroxide was added at the same time to control the system pH to 7.4-7.8. After the addition was completed, the system pH was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The mixture was stirred for 1-2 hours, filtered, rinsed with water, and the filter cake was added with 2.4 kg of water. 3.8 g of L-5-cysteine ​​was added, stirred and heated to 60±5°C, hydrochloric acid was added to adjust the system pH to 2.8-4.6, stirred for 0.5-2 hours, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain a refined product B: a refined L-5-methyltetrahydrofolate product, 130.5 g, with a yield of 69% and a purity of 98%.

[0105] Refined product B was added with 4% sodium hydroxide, 6.5g calcium ascorbate, 5.2g antioxidant 168, and 20.0g Egret A activated carbon to adjust the pH of the system to 7.0±0.2, decolorized at room temperature for 2 hours, filtered, and the filtrate was dripped into 2.0kg aqueous solution (containing 91.0g calcium chloride dihydrate and heated to 90-97°C), and 4% sodium hydroxide was added to control the pH of the system to 7.4-7.8. After the addition was completed, the pH of the system was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. Stir for 1-2 hours, filter, rinse with water, add 2.0kg water to the filter cake and beat at 40±5°C for 1 hour, filter, rinse with water and methanol in turn, and dry in vacuo at 50-70°C to obtain 112.5g of L-5-methyltetrahydrofolate calcium finished product with a yield of 72% (based on dry product) and a purity of 99.5%.

[0106] Structural identification: The above finished product was identified and confirmed to be L-5-methyltetrahydrofolate calcium, as follows:

[0107] (1) HPLC-MS

[0108] Test instrument: liquid chromatograph HPLC (model: Vanquish, manufacturer: Thermo Scientific)-combined quadrupole-Orbitrap mass spectrometer (model: Q Exactive, manufacturer: Thermo Scientific), chromatographic column: ZORBAXSB-C18 Rapid Resolution HD 1.8μm×2.1×50mm Agilent.

[0109] Ion source: ESI+, Type: high resolution mass spectrometer.

[0110] Testing unit: Beijing Zhongke Puyan Technology Co., Ltd.

[0111] The test results are shown in Table 1:

[0112] Table 1

[0113]

[0114]

[0115] According to the high-resolution mass spectrometry molecular weight of 460.19482, the molecular formula was calculated to be C 20 H 26 O6N7 (after ionization) is consistent with the product structure molecular formula.

[0116] (2) Infrared absorption spectrum

[0117] Instrument model: infrared spectrophotometer.

[0118] Test conditions and methods: The wavelength is selected as 400-4000nm.

[0119] Testing unit: Beijing Silian Pharmaceutical Co., Ltd.

[0120] The test results are shown in Table 2:

[0121] Table 2

[0122]

[0123] The above data show that the test sample contains aromatic groups (1606.76, 1573.97, 1514.17, 1477.52), quartet of benzene rings, carboxylic acid (3346.61), methyl, methylene, methine (2947.33, 2740.94, 2694.65, 1465.95, 960.58, 910.43, 769.62), imine and carbon-nitrogen double bonds (1344.43, 1192.05) and other groups. The types of groups contained in its molecular structure and its infrared spectral characteristics are consistent.

[0124] (3) Hydrogen spectrum 1 H-NMR

[0125] Test conditions: solvent D2O. The measurement results are shown in Table 3.

[0126] Table 3

[0127] Chemical shift Number of protons Proton assignment Multiplicity 7.3935、7.3724 2 Ar d 6.5710、6.5498 2 Ar d 4.2510、4.2378、4.2286、4.2151 1 CH dd 3.6084、3.5409、3.5327、3.5032、3.4354、3.4007 3 <![CDATA[CH、CH2]]> m 3.2059、3.1907 2 CH d 2.7676 3 <![CDATA[CH3]]> s 2.2490、2.2314、2.2136 2 <![CDATA[CH2]]> t 2.0020、1.9848、1.9682、1.9495、1.9344、1.9172 1 <![CDATA[CH2]]> dt 1.8630、1.8451、1.8243、1.8074、1.7878、1.7700 1 <![CDATA[CH2]]> dt

[0128] Example 2

[0129] This embodiment provides a method for preparing L-5-methyltetrahydrofolate calcium, which is as follows:

[0130] 500.0g of folic acid was added with 2.4kg of 4% sodium hydroxide and 12.0g of anhydrous lithium chloride, stirred at room temperature for 1 hour, and 400.0g of sodium borohydride was added in batches after about 2 hours, and the temperature was controlled at 0-30°C, and the reaction was allowed to proceed overnight. Hydrochloric acid was added dropwise, and after a large amount of gas was no longer generated, 500.0g of 50% p-toluenesulfonic acid was added dropwise, and when about half of the addition was completed, 20.0g of L-cysteine ​​hydrochloride was added, the temperature was raised to 55-65°C, and hydrochloric acid was continued to be added dropwise to adjust the system pH to 0.6-0.9, and the crude product A was filtered and washed with water.

[0131] The crude product A was stirred with about 2.5 kg of 4% sodium hydroxide to dissolve, and the temperature was raised to 55-65° C. to adjust the pH of the system to 5.5-7.5, and hydrochloric acid was added dropwise to adjust the pH of the system to 0.6-0.9, and 20.0 g of p-toluenesulfonic acid was added, stirred for 1.5 hours, filtered, rinsed with water and methanol in turn, and dried at 50-70° C. to obtain a refined product A: p-toluenesulfonate of 6(s)-tetrahydrofolate, about 268.0 g, with a yield of 38% and a purity of 98%.

[0132] To 265.0g of refined product A, add about 1.2kg of 4% sodium hydroxide and 6.5g of lithium hydroxide to adjust the pH of the system to 7.5-8.0, add 11.0g of L-cysteine ​​and 38.5g of formaldehyde (36%-38% aqueous solution) to react at room temperature for 30min, slowly add 13.8g of sodium borohydride, raise the temperature to 60-70°C and react for 3.5h, add hydrochloric acid dropwise to adjust the pH of the system to 2.8-4.6, stir for 0.5-2.0 hours until uniformly dispersed, filter, rinse with water and methanol in turn, and vacuum dry to obtain crude product B: crude L-5-methyltetrahydrofolate, 185.0g, yield 93%, purity 98%.

[0133] 4% sodium hydroxide was added to the crude product B to adjust the pH of the system to 7.0±0.1, 7.6 g of L-cysteine ​​was added, and the mixture was dripped into 15 parts of an aqueous solution (containing 133.0 g of calcium chloride dihydrate and heated to above 90°C), and 4% sodium hydroxide was added at the same time to control the pH of the system to 7.4-7.8. After the addition was completed, the pH of the system was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The mixture was stirred for 1-2 hours, filtered, rinsed with water, and the filter cake was added to 2.4 kg of water. 3.8 g of L-5-cysteine ​​was added, stirred and heated to 60±5°C, hydrochloric acid was added to adjust the pH of the system to 2.8-4.6, stirred for 0.5-2 hours, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain a refined product B: 120.5 g of L-5-methyltetrahydrofolate refined product, with a yield of 69% and a purity of 98%.

[0134] Refined product B was added with 4% sodium hydroxide, 5.2g L-cysteine, 5.2g antioxidant 1010, and 20.0g Egret B activated carbon to adjust the pH of the system to 7.0±0.2, decolorized at room temperature for 2 hours, filtered, and the filtrate was dripped into 2.0kg aqueous solution (containing 111.0g calcium acetate and heated to above 90°C), and 4% sodium hydroxide was added to control the pH of the system to 7.4-7.8. After the addition was completed, the pH of the system was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. Stir for 1-2 hours, filter, rinse with water, add 2.0kg water to the filter cake, beat at 40±5°C for 1 hour, filter, rinse with water and methanol in turn, and dry in vacuo at 50-70°C to obtain 98.5g of L-5-methyltetrahydrofolate calcium finished product with a yield of 68% (based on dry product) and a purity of 99.6%.

[0135] Example 3

[0136] This embodiment provides a method for preparing L-5-methyltetrahydrofolate calcium, which is as follows:

[0137] 500.0g of folic acid was added with 2.4kg of 4% sodium hydroxide and 35.0g of lithium carbonate, stirred at room temperature for 1 hour, and 400.0g of sodium borohydride was added in batches after about 2 hours, and the temperature was controlled at 0-30°C, and the reaction was allowed to proceed overnight. Citric acid was added in batches, and 500.0g of 50% p-toluenesulfonic acid was added dropwise after no more gas was generated in large quantities, and 20.0g of L-cysteine ​​hydrochloride was added when about half of the addition was completed, and the temperature was raised to 55-65°C, and citric acid was continued to be added to adjust the system pH to 0.6-0.9, and the crude product A was obtained by filtering and washing with water.

[0138] The crude product A was stirred with about 2.5 kg of 4% sodium hydroxide to dissolve, and the temperature was raised to 55-65° C. to adjust the system pH to 5.5-7.5, and citric acid was added dropwise to adjust the system pH to 0.6-0.9, and 20.0 g of p-toluenesulfonic acid was added, stirred for 1.5 hours, filtered, rinsed with water and methanol in turn, and dried at 50-70° C. to obtain a refined product A: p-toluenesulfonate of 6(s)-tetrahydrofolate, about 268.0 g, with a yield of 38% and a purity of 98%.

[0139] To 265.0g of refined product A, add about 1.2kg of 4% sodium hydroxide and 20.5g of lithium carbonate to adjust the pH of the system to 7.5-8.0, add 11.0g of calcium ascorbate and 38.5g of formaldehyde (36%-38% aqueous solution) and react at room temperature for 30min, slowly add 13.8g of sodium borohydride, raise the temperature to 60-70°C and react for 3.5h, add hydrochloric acid dropwise to adjust the pH of the system to 2.8-4.6, stir for 0.5-2.0 hours until it is evenly dispersed, filter, rinse with water and methanol in turn, and vacuum dry to obtain crude product B: crude L-5-methyltetrahydrofolate, 185.0g, yield 93%, purity 98%.

[0140] The crude product B was added with 4% sodium hydroxide to adjust the system pH to 7.0±0.1, 7.6 g of L-cysteine ​​was added, and the mixture was dripped into 15 parts of an aqueous solution (containing 133.0 g of calcium chloride dihydrate and heated to above 90°C), and 4% sodium hydroxide was added at the same time to control the system pH to 7.4-7.8. After the addition was completed, the system pH was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The mixture was stirred for 1-2 hours, filtered, rinsed with water, and the filter cake was added with 2.4 kg of water. 3.8 g of L-5-cysteine ​​was added, stirred and heated to 60±5°C, hydrochloric acid was added to adjust the system pH to 2.8-4.6, stirred for 0.5-2 hours, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain a refined product B: 130.5 g of L-5-methyltetrahydrofolate, with a yield of 69% and a purity of 98%.

[0141] 4% sodium hydroxide, 5.2g tea polyphenols, 5.2g antioxidant 1010, and 20.0g 767 activated carbon for injection were added to the refined product B to adjust the pH of the system to 7.0±0.2, decolorize at room temperature for 2 hours, filter, and drop the filtrate into 2.0kg aqueous solution (containing 142.0g calcium lactate and heated to above 90°C). At the same time, 4% sodium hydroxide was added to control the pH of the system to 7.4-7.8. After the addition was completed, the pH of the system was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. Stir for 1-2 hours, filter, rinse with water, add 2.0kg water to the filter cake, beat at 40±5°C for 1 hour, filter, rinse with water and methanol in turn, and dry in vacuo at 50-70°C to obtain 112.5g of L-5-methyltetrahydrofolate calcium finished product with a yield of 72% (based on dry product) and a purity of 99.5%.

[0142] Example 4

[0143] This embodiment provides a method for preparing L-5-methyltetrahydrofolate calcium, which is as follows:

[0144] 500.0g of folic acid was added with 2.68kg of 4% potassium hydroxide and 35.0g of lithium carbonate, stirred at room temperature for 1 hour, and 400.0g of sodium borohydride was added in batches after about 2 hours, and the temperature was controlled at 0-30°C, and the reaction was allowed to proceed overnight. Citric acid was added in batches, and 500.0g of 50% p-toluenesulfonic acid was added dropwise after no more gas was generated in large quantities, and 5g of sodium pyrosulfite was added when about half of the addition was completed, and the temperature was raised to 55-65°C, and citric acid was continued to be added to adjust the pH of the system to 0.6-0.9, and the crude product A was obtained by filtering and washing with water.

[0145] The crude product A was stirred with about 2.5 kg of 4% sodium hydroxide to dissolve, and the temperature was raised to 55-65° C. to adjust the system pH to 5.5-7.5, and citric acid was added dropwise to adjust the system pH to 0.6-0.9, and 20.0 g of p-toluenesulfonic acid was added, stirred for 1.5 hours, filtered, rinsed with water and methanol in turn, and dried at 50-70° C. to obtain a refined product A: p-toluenesulfonate of 6(s)-tetrahydrofolate, about 252 g, with a yield of 36% and a purity of 97.6%.

[0146] To 265.0g of refined product A, add about 1.2kg of 4% sodium hydroxide and 20.5g of lithium carbonate to adjust the pH of the system to 7.5-8.0, add 11.0g of calcium ascorbate and 38.5g of formaldehyde (36%-38% aqueous solution) and react at room temperature for 30min, slowly add 13.8g of sodium borohydride, raise the temperature to 60-70°C and react for 3.5h, add hydrochloric acid dropwise to adjust the pH of the system to 2.8-4.6, stir for 0.5-2.0 hours until it is evenly dispersed, filter, rinse with water and methanol in turn, and vacuum dry to obtain crude product B: crude L-5-methyltetrahydrofolate, 185.0g, yield 93%, purity 98%.

[0147] The crude product B was added with 4% sodium hydroxide to adjust the system pH to 7.0±0.1, 7.6 g of L-cysteine ​​was added, and the mixture was dripped into 15 parts of an aqueous solution (containing 133.0 g of calcium chloride dihydrate and heated to above 90°C), and 4% sodium hydroxide was added at the same time to control the system pH to 7.4-7.8. After the addition was completed, the system pH was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The mixture was stirred for 1-2 hours, filtered, rinsed with water, and the filter cake was added with 2.4 kg of water. 3.8 g of L-5-cysteine ​​was added, stirred and heated to 60±5°C, hydrochloric acid was added to adjust the system pH to 2.8-4.6, stirred for 0.5-2 hours, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain a refined product B: 130.5 g of L-5-methyltetrahydrofolate, with a yield of 69% and a purity of 98%.

[0148] 4% sodium hydroxide, 5.2g tea polyphenols, 5.2g antioxidant 1010, and 20.0g 767 activated carbon for injection were added to the refined product B to adjust the pH of the system to 7.0±0.2, decolorize at room temperature for 2 hours, filter, and drop the filtrate into 2.0kg aqueous solution (containing 142.0g calcium lactate and heated to above 90°C). At the same time, 4% sodium hydroxide was added to control the pH of the system to 7.4-7.8. After the addition was completed, the pH of the system was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. Stir for 1-2 hours, filter, rinse with water, add 2.0kg water to the filter cake, beat at 40±5°C for 1 hour, filter, rinse with water and methanol in turn, and dry in vacuo at 50-70°C to obtain 112.5g of L-5-methyltetrahydrofolate calcium finished product with a yield of 72% (based on dry product) and a purity of 99.5%.

[0149] Example 5

[0150] This embodiment provides a method for preparing L-5-methyltetrahydrofolate calcium, which is as follows:

[0151] 500.0g of folic acid was added with 2.4kg of 4% sodium hydroxide and 35.0g of lithium carbonate, stirred at room temperature for 1 hour, and 400.0g of sodium borohydride was added in batches after about 2 hours, and the temperature was controlled at 0-30°C, and the reaction was allowed to proceed overnight. Citric acid was added in batches, and 500.0g of 50% p-toluenesulfonic acid was added dropwise after no more gas was generated in large quantities, and 20.0g of L-cysteine ​​hydrochloride was added when about half of the addition was completed, and the temperature was raised to 55-65°C, and citric acid was continued to be added to adjust the system pH to 0.6-0.9, and the crude product A was obtained by filtering and washing with water.

[0152] The crude product A was stirred with about 2.5 kg of 4% sodium hydroxide to dissolve, and the temperature was raised to 55-65° C. to adjust the system pH to 5.5-7.5, and citric acid was added dropwise to adjust the system pH to 0.6-0.9, and 20.0 g of p-toluenesulfonic acid was added, stirred for 1.5 hours, filtered, rinsed with water and methanol in turn, and dried at 50-70° C. to obtain a refined product A: p-toluenesulfonate of 6(s)-tetrahydrofolate, about 268.0 g, with a yield of 38% and a purity of 98%.

[0153] To 265.0g of refined product A, add about 1.2kg of 4% sodium hydroxide and 20.5g of lithium carbonate to adjust the pH of the system to 7.5-8.0, add 11.0g of calcium ascorbate and 38.5g of formaldehyde (36%-38% aqueous solution) and react at room temperature for 30min, slowly add 13.8g of sodium borohydride, raise the temperature to 60-70°C and react for 3.5h, add hydrochloric acid dropwise to adjust the pH of the system to 2.8-4.6, stir for 0.5-2.0 hours until it is evenly dispersed, filter, rinse with water and methanol in turn, and vacuum dry to obtain crude product B: crude L-5-methyltetrahydrofolate, 185.0g, yield 93%, purity 98%.

[0154] The crude product B was added with 4% sodium hydroxide to adjust the system pH to 7.0±0.1, 7.6 g of L-cysteine ​​was added, and the mixture was dripped into 15 parts of an aqueous solution (containing 133.0 g of calcium chloride dihydrate and heated to above 90°C), and 4% sodium hydroxide was added at the same time to control the system pH to 7.4-7.8. After the addition was completed, the system pH was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The mixture was stirred for 1-2 hours, filtered, rinsed with water, and the filter cake was added with 2.4 kg of water. 3.8 g of L-5-cysteine ​​was added, stirred and heated to 60±5°C, hydrochloric acid was added to adjust the system pH to 2.8-4.6, stirred for 0.5-2 hours, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain a refined product B: 130.5 g of L-5-methyltetrahydrofolate, with a yield of 69% and a purity of 98%.

[0155] 4% sodium hydroxide, 5.2g tea polyphenols, 5.2g antioxidant 1010, and 20.0g 767 activated carbon for injection were added to the refined product B, and the pH of the system was adjusted to 7.0±0.2. The product was decolorized at room temperature for 2 hours, filtered, and the filtrate was mixed with 2.0kg aqueous solution (containing 142.0g calcium lactate). Then the system was heated to above 90°C, and 4% sodium hydroxide was added dropwise to control the pH of the system to 7.4-7.8. After the addition was completed, the pH of the system was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The product was stirred for 1-2 hours, filtered, and rinsed with water. The filter cake was added to 2.0kg water and pulped at 40±5°C for 1 hour, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain 102.5g of L-5-methyltetrahydrofolate calcium product with a yield of 66.8% (based on dry product) and a purity of 98.7%.

[0156] Example 6

[0157] This embodiment provides a method for preparing L-5-methyltetrahydrofolate calcium, which is as follows:

[0158] 500.0g of folic acid was added with 2.4kg of 4% sodium hydroxide and 35.0g of lithium carbonate, stirred at room temperature for 1 hour, and 400.0g of sodium borohydride was added in batches after about 2 hours, and the temperature was controlled at 0-30°C, and the reaction was allowed to proceed overnight. Citric acid was added in batches, and 500.0g of 50% p-toluenesulfonic acid was added dropwise after no more gas was generated in large quantities, and 20.0g of L-cysteine ​​hydrochloride was added when about half of the addition was completed, and the temperature was raised to 55-65°C, and citric acid was continued to be added to adjust the system pH to 0.6-0.9, and the crude product A was obtained by filtering and washing with water.

[0159] The crude product A was stirred with about 2.5 kg of 4% sodium hydroxide to dissolve, and the temperature was raised to 55-65° C. to adjust the system pH to 5.5-7.5, and citric acid was added dropwise to adjust the system pH to 0.6-0.9, and 20.0 g of p-toluenesulfonic acid was added, stirred for 1.5 hours, filtered, rinsed with water and methanol in turn, and dried at 50-70° C. to obtain a refined product A: p-toluenesulfonate of 6(s)-tetrahydrofolate, about 268.0 g, with a yield of 38% and a purity of 98%.

[0160] To 265.0g of refined product A, add about 1.2kg of 4% sodium hydroxide and 20.5g of lithium carbonate to adjust the pH of the system to 7.5-8.0, add 11.0g of calcium ascorbate and 38.5g of formaldehyde (36%-38% aqueous solution) and react at room temperature for 30min, slowly add 13.8g of sodium borohydride, raise the temperature to 60-70°C and react for 3.5h, add hydrochloric acid dropwise to adjust the pH of the system to 2.8-4.6, stir for 0.5-2.0 hours until it is evenly dispersed, filter, rinse with water and methanol in turn, and vacuum dry to obtain crude product B: crude L-5-methyltetrahydrofolate, 185.0g, yield 93%, purity 98%.

[0161] The crude product B was added with 4% sodium hydroxide to adjust the system pH to 7.0±0.1, 7.6 g of L-cysteine ​​was added, and the mixture was dripped into 15 parts of an aqueous solution (containing 133.0 g of calcium chloride dihydrate and heated to above 90°C), and 4% sodium hydroxide was added at the same time to control the system pH to 7.4-7.8. After the addition was completed, the system pH was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The mixture was stirred for 1-2 hours, filtered, rinsed with water, and the filter cake was added with 2.4 kg of water. 3.8 g of L-5-cysteine ​​was added, stirred and heated to 60±5°C, hydrochloric acid was added to adjust the system pH to 2.8-4.6, stirred for 0.5-2 hours, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain a refined product B: 130.5 g of L-5-methyltetrahydrofolate, with a yield of 69% and a purity of 98%.

[0162] Refined product B was added with 4% sodium hydroxide, 10.4g antioxidant 1010, and 20.0g 767 activated carbon for injection, and the pH of the system was adjusted to 7.0±0.2. The product was decolorized at room temperature for 2 hours, filtered, and the filtrate was dripped into 2.0kg aqueous solution (containing 142.0g calcium lactate and heated to above 90°C). At the same time, 4% sodium hydroxide was added to control the pH of the system to 7.4-7.8. After the addition was completed, the pH of the system was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The product was stirred for 1-2 hours, filtered, and rinsed with water. The filter cake was added to 2.0kg water and pulped at 40±5°C for 1 hour, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain 124.6g of L-5-methyltetrahydrofolate calcium product with a yield of 62.3% (based on dry product) and a purity of 99.2%.

[0163] Comparative Example 1

[0164] This comparative example provides a method for preparing L-5-methyltetrahydrofolate calcium, which is as follows:

[0165] 500.0g of folic acid was added with 2.4kg of 4% sodium hydroxide and 35.0g of lithium carbonate, stirred at room temperature for 1 hour, and 400.0g of sodium borohydride was added in batches after about 2 hours, and the temperature was controlled at 0-30°C, and the reaction was allowed to proceed overnight. Citric acid was added in batches to adjust the pH of the system to 3.2-3.8. The reaction liquid was in a slurry state, filtered, and the filter cake was washed with water to obtain crude tetrahydrofolic acid.

[0166] Add 4 kg of water to the crude tetrahydrofolate, then add 333.0 g of benzenesulfonic acid, add 20.0 g of L-cysteine ​​hydrochloride, raise the temperature to 55-65°C, continue to add citric acid to adjust the pH of the system to 0.6-0.9, filter and wash with water to obtain crude product A.

[0167] The crude product A was stirred with about 2.5 kg of 4% sodium hydroxide to dissolve, and the temperature was raised to 55-65° C. to adjust the system pH to 5.5-7.5, and citric acid was added dropwise to adjust the system pH to 0.6-0.9, and 20.0 g of benzenesulfonic acid was added, stirred for 1.5 hours, filtered, rinsed with water and methanol in turn, and then this step was repeated once. The filter cake was dried at 50-70° C. to obtain a refined product A: 6(s)-tetrahydrofolate benzenesulfonate, about 188.0 g, with a yield of 27.6% and a purity of 89.5%.

[0168] To 188.0g of refined product A, add about 0.8kg of 4% sodium hydroxide and 14.0g of lithium carbonate to adjust the pH of the system to 7.5-8.0, add 28.1g of formaldehyde (36%-38% aqueous solution) and react at room temperature for 30min, slowly add 11.7g of sodium borohydride, raise the temperature to 60-70°C and react for 3.5h, add hydrochloric acid dropwise to adjust the pH of the system to 2.8-4.6, stir for 0.5-2.0 hours until uniformly dispersed, filter, rinse with water and methanol in turn, and vacuum dry to obtain crude product B: crude L-5-methyltetrahydrofolate, 125.0g, yield 92%, purity 94.3%.

[0169] The crude product B was added with 4% sodium hydroxide to adjust the system pH to 7.0±0.1, 7.6 g of L-cysteine ​​was added, and the mixture was dripped into 15 parts of an aqueous solution (containing 133.0 g of calcium chloride dihydrate and heated to above 90°C), and 4% sodium hydroxide was added at the same time to control the system pH to 7.4-7.8. After the addition was completed, the system pH was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The mixture was stirred for 1-2 hours, filtered, rinsed with water, and the filter cake was added with 2.4 kg of water. 3.8 g of L-5-cysteine ​​was added, stirred and heated to 60±5°C, hydrochloric acid was added to adjust the system pH to 2.8-4.6, stirred for 0.5-2 hours, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain a refined product B: 130.5 g of L-5-methyltetrahydrofolate, with a yield of 69% and a purity of 98%.

[0170] 4% sodium hydroxide, 5.2g tea polyphenols, 5.2g antioxidant 1010, and 20.0g 767 activated carbon for injection were added to the refined product B, and the pH of the system was adjusted to 7.0±0.2. The mixture was decolorized at room temperature for 2 hours, filtered, and the filtrate was dripped into 2.0kg aqueous solution (containing 92.0g calcium lactate and heated to above 90°C). At the same time, 4% sodium hydroxide was added to control the pH of the system to 7.4-7.8. After the addition was completed, the pH of the system was adjusted to be stable at 7.5±0.1 and the temperature was ≥90°C. The mixture was stirred for 1-2 hours, filtered, and rinsed with water. The filter cake was added to 2.0kg water and pulped at 40±5°C for 1 hour, filtered, rinsed with water and methanol in turn, and dried in vacuo at 50-70°C to obtain 102.5g of L-5-methyltetrahydrofolate calcium product with a yield of 72% (based on dry product) and a purity of 99.2%.

[0171] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0172] The above-described embodiments only express several implementation methods of the present invention, which are convenient for understanding the technical solutions of the present invention in detail, but they cannot be understood as limiting the scope of protection of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. It should be understood that the technical solutions obtained by those skilled in the art through logical analysis, reasoning or limited experiments on the basis of the technical solutions provided by the present invention are all within the protection scope of the claims attached to the present invention. Therefore, the protection scope of the patent of the present invention shall be based on the contents of the attached claims, and the description can be used to interpret the contents of the claims.

Claims

1. A method for preparing L-5-methyltetrahydrofolate calcium, characterized in that: The steps include: Mixing folic acid, a first reducing agent, a first catalyst and a first alkaline solvent to perform a reduction reaction to prepare (R,S)-6-tetrahydrofolic acid; The (R,S)-6-tetrahydrofolate, p-toluenesulfonic acid and the first antioxidant are mixed and chiral separation is performed to prepare 6(S)-tetrahydrofolate p-toluenesulfonate; The 6(S)-tetrahydrofolate p-toluenesulfonate, the methylating agent and the second alkaline solvent are mixed to perform a methylation reaction, and the product of the methylation reaction, the second reducing agent and the second catalyst are mixed to perform a ring-opening reaction to prepare L-5-methyltetrahydrofolate; The L-5-methyltetrahydrofolate, the second antioxidant and the third alkaline solvent are mixed, decolorized, filtered, and the filtrate is reacted with calcium salt to form a salt to prepare L-5-methyltetrahydrofolate calcium; Wherein, the first catalyst and the second catalyst are independently selected from one or more of lithium chloride, lithium hydroxide, lithium carbonate and lithium sulfate; The first alkaline solvent, the second alkaline solvent and the third alkaline solvent are independently selected from a 3% to 5% sodium hydroxide aqueous solution, a 4% to 6% potassium hydroxide aqueous solution or a 5% to 7% sodium carbonate aqueous solution; The first reducing agent and the second reducing agent are independently selected from one of sodium borohydride, sodium cyanoborohydride and sodium triacetoxyborohydride; The first antioxidant is selected from one or more of thiourea dioxide and L-cysteine ​​hydrochloride; The second antioxidant is selected from a mixture of tea polyphenols, antioxidant 1010 and L-cysteine, or a mixture of calcium ascorbate and antioxidant 168; The mass ratio of the folic acid, the first reducing agent and the first catalyst is 1:(0.6-1.2):(0.02-0.05); and / or The mass ratio of the (R,S)-6-tetrahydrofolate, the p-toluenesulfonic acid and the first antioxidant is 1:(0.48-0.55):(0.01-0.1); The reaction temperature of the reduction reaction is 0°C to 30°C.

2. The method for preparing L-5-methyltetrahydrofolate calcium according to claim 1, characterized in that: The calcium salt is selected from one or more of calcium chloride, calcium chloride dihydrate, calcium lactate, calcium acetate and calcium aspartate.

3. The method for preparing L-5-methyltetrahydrofolate calcium according to claim 1, characterized in that: The mass ratio of the 6(S)-tetrahydrofolate toluenesulfonate, the methylating agent, the second reducing agent and the second catalyst is 1:(0.12-0.16):(0.03-0.07):(0.02-0.05); and / or The mass ratio of the L-5-methyltetrahydrofolate, the second antioxidant and the calcium salt is 1:(0.02-0.1):(0.5-1.2).

4. The method for preparing L-5-methyltetrahydrofolate calcium according to any one of claims 1 to 3, characterized in that: The methylation reaction satisfies one or more of the following conditions: (1) The reaction temperature is 15℃~30℃; (2) The reaction time is 20min~60min.

5. The method for preparing L-5-methyltetrahydrofolate calcium according to any one of claims 1 to 3, characterized in that: The ring-opening reaction satisfies one or more of the following conditions: (1) The reaction temperature is 65℃~75℃; (2) The reaction time is 2h~5h.

6. The method for preparing L-5-methyltetrahydrofolate calcium according to any one of claims 1 to 3, characterized in that: The salt-forming reaction satisfies one or more of the following conditions: (1) The reaction temperature is 90℃~95℃; (2) pH is 7.5~7.

8.

7. Use of the preparation method of L-5-methyltetrahydrofolate calcium according to any one of claims 1 to 6 in the preparation of medicines, foods or health products.